EOLS - Evolus, Inc. News

Discover

EOLS

Evolus, Inc.

5.80

4 x 5.61

1 x 5.90

bid

ask

0.00

0.00%

09:31 AM

timesize

Ytd	-12.71%
1y	-39.34%

5.70

day range

5.81

3.94

52 week range

9.65

Open	5.81	Prev Close	5.80	Low	5.70	High	5.81	Mkt Cap	382.29M
Vol	5.11K	Avg Vol	842.03K	EPS	-0.44	P/E	-13.32	Forward P/E	54.20
Beta	1.32	Short Ratio	7.38	Inst. Own	80.22%	Dividend	N/A	Div Yield	N/A
Ex Div Date	N/A	Earning	08-04	50-d Avg	6.53	200-d Avg	5.89	1yr Est	23.43

EOLS News

businesswire.com

Evolus to Report Second Quarter Financial Results on August 5, 2026

NEWPORT BEACH, Calif.--(BUSINESS WIRE)--Evolus, Inc. (NASDAQ: EOLS), a performance beauty company wi

businesswire.com

Evolus Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

NEWPORT BEACH, Calif.--(BUSINESS WIRE)--Evolus, Inc. (NASDAQ: EOLS), a performance beauty company wi

benzinga.com

Evolus Enters Into Exclusive Licensing And Distribution Agreement With IBSA To Develop And Commercia

Evolus, Inc. (NASDAQ:EOLS), a global performance beauty company with a focus on building an aestheti

businesswire.com

Evolus Announces Partnership with IBSA to Develop and Commercialize Market-Leading Profhilo® in the

NEWPORT BEACH, Calif.--(BUSINESS WIRE)--Evolus, Inc. (NASDAQ: EOLS), a global performance beauty com

businesswire.com

Evolus to Participate in The Jefferies Global Healthcare Conference

NEWPORT BEACH, Calif.--(BUSINESS WIRE)--Evolus, Inc. (NASDAQ: EOLS), a performance beauty company wi

businesswire.com

Evolus Announces Commercial Launch of Estyme® Injectable Hyaluronic Acid Gels in Europe

NEWPORT BEACH, Calif.--(BUSINESS WIRE)--Evolus, Inc. (NASDAQ: EOLS), a global performance beauty com

seekingalpha.com

Evolus, Inc. (EOLS) Q1 2026 Earnings Call Transcript

zacks.com

Evolus, Inc. (EOLS) Reports Q1 Loss, Tops Revenue Estimates

Evolus, Inc. (EOLS) came out with a quarterly loss of $0.1 per share versus the Zacks Consensus Esti

businesswire.com

Evolus Reports First Quarter 2026 Financial Results; Company Delivers Second Consecutive Quarter of

NEWPORT BEACH, Calif.--(BUSINESS WIRE)--Evolus, Inc. (NASDAQ: EOLS), a global performance beauty com

benzinga.com

Norwegian Cruise Line, Aura Biosciences And Other Big Stocks Moving Lower In Monday's Pre-Market Ses

US stock futures lower, Dow futures down 200 points. Norwegian Cruise Line shares fall after Q1 resu

benzinga.com

Earnings Scheduled For May 4, 2026

benzinga.com

Why eBay Shares Are Trading Higher By 8%; Here Are 20 Stocks Moving Premarket

eBay (NASDAQ: EBAY) rose sharply after GameStop (NYSE: GME) proposed to acquire it for $125/share, v

defenseworld.net

Evolus Targets Double-Digit Growth, Full-Year Profitability at Needham Healthcare Conference

Evolus (NASDAQ: EOLS) executives told investors at Needham and Company's 25th Annual Healthcare Conf

businesswire.com

Evolus to Report First Quarter Financial Results on May 4, 2026

NEWPORT BEACH, Calif.--(BUSINESS WIRE)--Evolus, Inc. (NASDAQ: EOLS), a performance beauty company wi

defenseworld.net

JPMorgan Chase & Co. Decreases Stake in Evolus, Inc. $EOLS

JPMorgan Chase and Co. decreased its holdings in Evolus, Inc. (NASDAQ: EOLS) by 35.5% in the undefin

businesswire.com

Evolus to Participate in the Needham 25th Annual Virtual Healthcare Conference

NEWPORT BEACH, Calif.--(BUSINESS WIRE)--Evolus, Inc. (NASDAQ: EOLS), a performance beauty company wi

defenseworld.net

Evolus (NASDAQ:EOLS) Insider Sells $14,815.25 in Stock

Evolus, Inc. (NASDAQ: EOLS - Get Free Report) insider Rui Avelar sold 3,119 shares of the firm's sto

businesswire.com

Evolus Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

NEWPORT BEACH, Calif.--(BUSINESS WIRE)--Evolus, Inc. (NASDAQ: EOLS) a performance beauty company wit

defenseworld.net

Evolus Sees Toxin Market Stabilizing, Evolysse Gaining Traction, Raises 2028 Revenue Targets at Conf

Evolus (NASDAQ: EOLS) executives said they are seeing signs of stabilization and improvement in the

defenseworld.net

Evolus, Inc. (NASDAQ:EOLS) Receives $17.50 Average Target Price from Analysts

Shares of Evolus, Inc. (NASDAQ: EOLS - Get Free Report) have been assigned a consensus rating of "Mo

fool.com

Why Evolus Stock Soared Today

Demand for Evolus' beauty products is growing. Management expects to generate sustainable profits in

benzinga.com

12 Health Care Stocks Moving In Wednesday's Intraday Session

benzinga.com

12 Health Care Stocks Moving In Wednesday's Pre-Market Session

seekingalpha.com

Evolus, Inc. (EOLS) Q4 2025 Earnings Call Transcript

zacks.com

Evolus, Inc. (EOLS) Matches Q4 Earnings Estimates

Evolus, Inc. (EOLS) came out with quarterly earnings of $0.06 per share, in line with the Zacks Cons

businesswire.com

Evolus Reports Fourth Quarter and Full-Year 2025 Financial Results; Delivers Sixth Consecutive Year

NEWPORT BEACH, Calif.--(BUSINESS WIRE)--Evolus, Inc. (NASDAQ: EOLS), a global performance beauty com

benzinga.com

Earnings Scheduled For March 3, 2026

benzinga.com

Alphabet To Rally Around 22%? Here Are 10 Top Analyst Forecasts For Thursday

benzinga.com

Earnings Scheduled For November 5, 2025

benzinga.com

Earnings Scheduled For August 5, 2025

benzinga.com

Earnings Scheduled For May 7, 2025

benzinga.com

Earnings Scheduled For March 4, 2025

benzinga.com

12 Health Care Stocks Moving In Wednesday's Intraday Session

benzinga.com

Stocks That Hit 52-Week Lows On Monday

benzinga.com

Stocks That Hit 52-Week Lows On Thursday